Send me a link:

*Text messaging rates may apply.

 Dow Up0.13% Nasdaq Down0.10%

Enzo Biochem Inc. (ENZ)

-NYSE
4.74 Down 0.27(5.39%) 4:04PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingApr 30, 2014Jan 31, 2014Oct 31, 2013Jul 31, 2013
Total Revenue 23,979   22,927   24,134   23,270  
Cost of Revenue13,583  13,158  13,555  13,823  
Gross Profit 10,396   9,769   10,579   9,447  
Operating Expenses
Research Development849  832  817  921  
Selling General and Administrative10,605  10,083  10,529  10,314  
Non Recurring(505)2,408  2,253  1,602  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (553) (3,554) (3,020) (3,390)
Income from Continuing Operations
Total Other Income/Expenses Net152  35  358  (169)
Earnings Before Interest And Taxes(448)(3,571)(2,724)(3,534)
Interest Expense -   -   -   -  
Income Before Tax(448)(3,571)(2,724)(3,534)
Income Tax Expense7  (5)63  (432)
Minority Interest -   -   -   -  
Net Income From Continuing Ops(455)(3,566)(2,787)(3,102)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (455) (3,566) (2,787) (3,102)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (455) (3,566) (2,787) (3,102)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.